Objective: To outline the usefulness of videothoracoscopic and videoassisted surgery in the final staging, resectability evaluation and treatment of lung cancer, and its possible advantages over thoracotomy. Patients and method: Videothoracoscopy was performed on 296 patients suffering from lung cancer. Patient selection criteria are described, as well as techniques for the different kinds of resections. Postoperative care and patient follow-up is also detailed. Results: Of the 296 patients 189 were operated on by open surgery after final staging and resectability evaluation. A total of 30 were considered unresectable by videothoracoscopic exploration, five cases needed exploratory thoracotomy to determine the resectability and in the remaining 72 cases the pulmonary resection was performed by videoassisted surgery: 21 pneumonectomies, five bilobectomies and 46 lobectomies. Three patients were rescued for surgery, after it was proven by intrapericardical videothoracoscopic exploration that the pulmonary artery was free at this level. The mean hospital stay was 48 h for the videothoracoscopic exploration and 6.8 days for the major lung resections. There were ten patients with complications (14%). The perioperatory mortality (30 days) was three cases (4.2%). The outcome (3-40 months follow-up) at the end of the study period was 62% patients alive and free of disease. Discussion: The applications of videothoracoscopic and videoassisted surgery in the treatment of lung cancer are considered: final staging, resectability evaluation, nodule biopsy and major resections with mediastinal lymphadenectomy. Their advantages include minimized pain, better cosmetic results, a shorter hospital stay and fewer complications. © 1997 Elsevier Science B.V.
Introduction
In 1992 Roviaro et al. [15] , communicated the first successful lobectomy performed by videoassisted thoracic surgery (VATS) showing that a lung cancer could be treated adequately using this approach. He described the surgical technique for this kind of operation.
Landrenaeau et al. [9] published the techniques and the basic strategies of VATS, which were followed in this study with slight modifications. Lewis [7, 11] described a technique for endoscopic lobectomy without hilar dissection.
Several studies [12, 18, 20, 21] have shown the possibility of performing a final staging and surgical evaluation of lung cancer resectability by meticulous optical and surgical exploration of the pleural and pericardial cavities, making exploratory thoracotomy almost completely redundant.
The aim of this paper is dual. First, to show the possibility of performing, after a complete clinical stag-ing, an exact evaluation of lung cancer resectability without the need to open the chest, resulting in a considerable decrease in the number of exploratory thoracotomies. Second, to outline the experience gained during this study using VATS for major lung resections -comparable to open surgery but with better immediate results.
Nevertheless, the problems with videothoracoscopic exploration (VTE) and VATS cannot be ignored, as that communicated by Fry [2] and commented on by Allen and Pairolero [1] , where a neoplastic implant in the extraction port of a cancerous nodule resulted in a fatality.
Patients and method
The time period for our study lasted from July 1992 until September 1996. From July 1992 to March 1993 all the patients explored by videothoracoscopy were immediately opened by thoracotomy to check our findings at VTE. In March 1993, after the earlier investigations, we decided not to open the patients considered unresectables by VTE, and exploratory thoracotomy was performed only on doubtful cases or when a thoracoscopy was not possible (i.e. hard adhesions).
Before being submitted to surgery, every patient had been explored by plain chest X-ray, bronchofibroscopy, high resolution CT scan, respiratory function tests, measurement of pulmonary artery pressures, as well as analytic and any, and all, other studies judged necessary to obtain an accurate clinical neoplastic staging and to determine the possibility of resectioning, or not, in each case.
The indications' criteria for performing VATS lobectomy or pneumonectomy can be seen in Table 1 . With regard to N2 cases we have to say that some clinical N0 -N1 were p-N2 on pathological examination. So operation on certain N2 lung cancers was begun, using VATS, by performing a radical lymphadenectomy after lung exeresis, which can be done in a similar radicality to the one in open surgery.
Surgical techniques
The first step of the operation is a VTE to perform the final staging and the evaluation of resectability of each case.
The procedure begins with the inspection of the pleural cavity, including the tumor area (which is possible in peripheral tumors but not in central ones) and the mediastinum (its immobility tends to be a sign of invasion or metastasis) for the presence or absence of lymphatic nodes in the characteristic areas, the fissures and possible transfissural invasions, the presence of unknown pleural metastasic seeding in cases without effusion, and every other possible cause of unresectability.
Also, through two more working ports, occasionally three, the mediastinum is explored in a surgical manner, performing a dissection as complete as necessary, and taking biopsy samples of doubtful areas. When the invasion over the pulmonary vessels precludes access to verify the resectability, the exploration can be performed inside the pericardial cavity, by opening the pericardium, what allows exploration of the pulmonary artery and veins (we have performed five such explorations: three cases were resected by open surgery with intrapericardial dissection of the vessels; two were considered unresectables because of arterial invasion up to its root).
The undiagnosed pulmonary nodules can also be biopsied to obtain a true diagnosis: of 20 cases, eight of them were carcinomas, which were resectioned in the same operation (five by thoracotomy and three by VATS).
To perform VATS lobectomy or pneumonectomy a utility thoracotomy of 5 cm length was used, anteriorly placed in the fourth or fifth space, without a ribspreader which has been occasionally used to extract the specimen.
The camera placed through the inferior port, was changed during the procedure to the anteriosuperior port, especially when the arteries of upper lobes were dissected.
For the dissection both endoscopic and conventional instruments were used, the latter through the minithoracotomy.
The vascular sutures were performed with an endostapler linear cutter (staple height, 2.5 mm), as well as the bronchial sutures (staple height for lobectomy-3.5 mm, for pneumonectomy -4.8 mm), or parenchymatous (3.5 mm). In the case of pneumonectomy the artery was first sutured with an endostapler linear cutter without a blade and then distally to that it was sutured and cut with one with a blade. The main stem bronchus was also sutured with a device without a blade and cut distal to the suture line which has six rows of staples. An important difference between this procedure and open surgery is the fact that the veins are always dissected and cut before the artery, in order to have good access to the artery. The specimen was always extracted into a plastic bag, to avoid risk of the tumor seeding in the wall.
After the lung exeresis a radical lymphadenectomy was performed, similar to open surgery. The only sites that require discussion here are the subcarinal areas. The right subcarinal space must be approached from behind, between the oesophagus and the bronchial tree, up to the main carina. The left main stem bronchus should be visible: 4-5 cm at the end of the dissection. This space may also be approached anteriorly, but only after upper right lobectomy, a procedure which does not exclude a posterior approach (which is actually the more complete).
After an upper left lobectomy the left subcarinal space must be approached anteriorly over the upper pulmonary vein stump. It is an easy way to accede to the main carina, which can then be freed of lymphatic nodes. Following a lower lobectomy the approach to the carina is anterioinferior over the vein stump. A pulling upward of the bronchial stump facilitates the manoeuvre.
The nodes were also extracted into a small plastic bag.
Once the operation was finished air leaks were checked with a saline serum test and two drains were left in the lobectomies in the same way as in open surgery, using the inferior and anteriosuperior ports.
Patients
From March 1993 to September 1996 296 patients suffering from lung cancer have been treated using the technique described above.
The patient-age ranged from 35 to 82 years (average 61.2 years), of which 244 were male and 52 were female.
Each one of the patients was clinically explored by (a) chest X-ray, (b) bronchofibroscopy, (c) high resolution CT scan, (d) respiratory function tests, (e) measurement by catheterism of the pulmonary artery pressure, free and after blockade, and (f) analytic examinations.
Routine mediastinoscopy was not performed because it was thought that N2 without bulky nodes is a condition requiring surgery followed by chemotherapy and radiotherapy. Only in suspected N3 or bulky N2 was mediastinoscopy performed to assess the stage and to carry out neoadjuvant therapy if the stage was confirmed.
All 296 patients were submitted to videothoracoscopic exploration as described above. After that 30 Table 2 .
The drains were withdrawn between 2-4 days, except when extended air leaks or pleural effusions were found present.
Results
Regarding the results, it was necessary to differentiate clearly between the exploratory procedures and the resections using VATS.
VTE
All 296 patients were submitted to VTE, instead of exploratory thoracotomy, to evaluate the resectability of their tumors. A total of 261 of them were considered resectable; the operation was then continued in 189 patients using conventional thoracotomy procedures, and in the other 72 cases using VATS.
However, using only VTE, 30 patients (10.1%) were considered clearly non-resectable. In each of the remaining five cases an exploratory thoracotomy was performed because hard pleural adhesions prevented the VTE or because doubts about the resectability necessitated open surgery. All of these were minithoracotomies (about 7-10 cm) assisted by video and all of the cases were non-resectable.
The 30 cases of unresectability were considered so by VTE because of: (a) non-suspected lesions in preoperative studies (15 pleural carcinomatosis, without pleural effusion, in cases c-T1-T2, N0 and M0); (b) doubtful tumoral invasion at CT scanning (eight mediastinal invasions bigger than the CT shows); (c) both conditions together (four cases: carcinomatosis and mediastinal invasion, though the mediastinal invasion was perhaps resectable in two of them); (d) transfissural invasion preventing lobectomy, including sleeve (three cases; patients that cannot tolerate a pneumonectomy for functional reasons: poor respiratory function tests and/or very high mean pulmonary artery pressure). It is striking that the rate of 'pure exploratory thoracotomy' in this study was only 1.68%.
On the other hand, it has to be emphasized that it was possible to rescue for surgery three patients considered non-resectable in other hospitals because of the suspected invasion of the pulmonary artery up to its origin at CT scanning. The intrapericardial VTE identified, in these three cases, minimal arterial invasion. An intrapericardial pneumonectomy was then performed. In the other two patients, however, intrapericardial VTE showed arterial invasion up to the main pulmonary artery bifurcation and the unresectability of these cases.
The operating time for VTE ranges from 10 min, in clearly resectable or non-resectable (i.e. pleural carcinomatosis) cases, up to 45 min in difficult cases or those for intrapericardial exploration. It's important to bear in mind that in these cases VTE is a complete surgical exploration, with the dissection of the hilum and all other areas necessary to determine exactly the resectability, equal in all ways to open surgery, but without actually opening the chest.
The mean postoperatory hospital stay of VTE was 48 h, without complication nor mortality, and an excellent recovery.
The analgesia was simple, with minimal doses of magnesic metamizol (2 g IV twice daily for the first day; 575 mg twice orally for the following 3 days).
Major lung exeresis by VATS
There are several points to emphasize here: The number of lobectomies (uni or bi) (n = 51) was greater than the number of pneumonectomies (n = 21) since the indications for this last group are more restrictive.
The mean operating time for VATS resection, once VTE is completed, was 150 min for lobectomy and 120 min for pneumonectomy -which tended to decrease as experience increased. This length of time may appear short, but one has to consider that VATS avoids the time taken up with opening and closing. If we consider the complete time (VTE+ VATS) we have to add a mean time of 14 min for VTE to the procedure (164 min for lobectomy and 134 min for pneumonectomy).
The test results for lymphadenectomy by VATS were a mean number of 14 nodes, ranging from eight to 21. Changes in the clinical stage (over and downstaging) were also observed (Table 3 ). This showed that some c-N0 were N2 on pathological examination. Originally, it was intended to operate on T1-T2 and N0 by VATS only but with these results a resectioning of some c-N2 was begun: to date three pneumonectomies and three lobectomies; one of them despite clinical staging was p-N0 on pathological examination.
The conversion rate to open surgery was low in this series: three cases; two of them because of bleeding, controlled by clamping before opening, and the other one because invasion of the pulmonary artery was discovered after the section of vein (an intrapericardial pneumonectomy was carried out). In four more cases we have had haemorrhages: three from pulmonary artery branches and one from the left upper pulmonary vein, but all of they were controlled by VATS and the procedure finished. In another two cases (lobectomies) the stapler cut but did not staple the bronchus, which was then manually sutured through the minithoracotomy with an endo-needleholder, without problems.
The postoperative pain was slight in all cases and very slight in comparison to open surgery. The mean analgesia dose was one third of that used in open surgery (magnesic metamizol IV, 2 g every 12 h for 2 days followed by 575 mg orally every 6 h for 4 days).
The mean postoperative hospital stay was 6.8 days. A middle lobectomy had been performed on the patient with the longest stay; 12 days with extended air leak.
Morbidity was not high at 13.8% (ten patients) ( Table 4 ). There were three cases (4.3%) of perioperatory mortality (30 days): one acute myocardial infarction and two sepsis for nosocomial infections.
The long follow-up for patients (Table 5) of between 3 and 40 months is similar to that for open surgery, but the global survival rate is very high at 62.9% for all the patients. This is probably due to the selection of cases I  11  9  T1N0M0  46  T2N0M0II  9  T1N1M0  1  0  T2N1M0  16   III-a  0  T1N2M0  0  T2N2M0  12  6  0  T3N0- 4. Finally, VATS allows major lung resectioning (segmentectomy, lobectomy and pneumonectomy), with radical mediastinal lymphadenectomy with the same oncologic criteria as for open surgery. Perhaps the most important point of discussion regarding VATS, at present, is whether the major lung resection should be done this way or not. It is believed [3, 7, 11, 14, [16] [17] [18] [19] that with a judicious selection of cases the results for VATS lobectomy may be similar to those for open surgery in the long term, but with better immediate recovery.
The other point of discussion is regarding the applicability of VATS for radical lymphadenectomy. Up to date only a few surgeons [3, 16, 17] along with ourselves, are performing lymphadenectomy after VATS lobectomy, sometimes [18] when necessary after node sampling. Our experience in this field shows that the number of nodes obtained in VATS lymphadenectomy is similar to that obtained in open surgery, and so we believe that radical lymphadenectomy should be always performed with VATS, like in thoracotomy. We think a comparative prospective trial of both techniques is necessary to obtain a true representation of survival after a long follow-up, because it is true that indications for performing VATS lobectomy are restrictive (T1-T2, N0) and can make a difference in the simple comparison of results for both techniques. Nevertheless, operation on N2 cases using VATS has begun, performing a routine radical lymphadencetomy of all lymphatic areas, as described in the text, even though it is thought that clinical N2 with nodes greater than 2 cm should not be operated on by VATS at the moment. Perhaps with increased surgical experience and more sophisticated instruments it will be possible in the future.
The conversion rate to open surgery is also an important fact, although it must always be borne in mind that if there are technical difficulties, doubts about resectability or problems (i.e. bleeding) open surgery is imperative. One has to think that a conversion to open surgery is not a defeat but the logical and wise decision of an experienced surgeon. Nevertheless, the conversion rate is not very high [12, 17, 22] and most of the cases were converted because of technical difficulties rather than bleeding or surgical complications of the procedure [6, 12, 18] and the rate diminishes as the surgeons' experience increases.
This study demonstrated that VATS presents some advantages over open surgery [3, 6, [16] [17] [18] 20] : (a) less pain; (b) smaller aggression-as the open surgery is like two operations, one on the wall and the other on the lung; (c) fewer and less serious postoperative complications, influenced by the rapid functional recovery; and (d) a shorter hospital stay and lower costs-considerations which are becoming more and more important. Furthermore, the cosmetic aspect of the scar, though it will not be vital, it is of great importance to many patients. and more probably due to the fact that the follow-up time is still too short, and the number of patients was too small to group by stage, type of tumor and operation. It's important to emphasize that ports or minithoracotomy tumor seeding have not been recorded.
Discussion
VATS has various action fields in lung cancer surgery: 1. Final staging and evaluation of the resectability: proving parietal invasion, lymphatic nodes, showing unknown pleural metastasis, exact location and degree of invasion in certain tumors avoiding unnecessary exploratory thoracotomies. Several surgical groups [3, 8, 12, [16] [17] [18] 20] agree with this policy of performing only exploratory thoracotomy in cases of hard pleuropulmonary symphysis or when there's serious doubt about resectability. In this study the percentage of 'pure exploratory thoracotomies', following this policy, was 1.68%, and the percentage of unresectable cases in VTE was 10.1%. A significant number of unnecessary thoracotomies were thus avoided.
2. A biopsy of pulmonary nodules histologically unknown with a minimal aggression [4, 5, 10, 13, 22] is one of the fundamental indications of the VATS in the management of lung cancer. Twelve of the 20 cases of solitary nodules were not cancerous and they did not need a thoracotomy for correct diagnosis.
3. Wedge resections and lymphadenectomy in cancers, for patients who do not permit a major exeresis, for functional reasons, or an iterative exeresis, even though this is not an ideal operation for lung cancer [12, 18, 19] . However, it is also necessary to state that, at present, there are draw-backs such as an endoscopic equipment limitation and the need for special training, to which not all the surgeons are favourably disposed. Finally, it must be indicated that because of these draw-backs, only 15-25% of the patients suffering from lung cancer at the moment, can be operated on using VATS [3, 7, 11, 17, 18] , since one must make a strict selection of cases (though the criteria could be widened with experience).
As a result of this study, it is thought that VATS will not be able to substitute completely for open surgery.
Conclusions
1. Lung cancer surgery is perfectly feasible using VATS, with risks similar to those for thoracotomy. 2. At the moment a strict selection of cases is necessary, though the number and type of indications are widening as experience is gained and the equipment is perfected. 3. It is perfectly possible to respect the rules for oncologic surgery using VATS, even to perform mediastinal lymphadenectomy, for N2 cases, with no bulky nodes. 4. The advantages of VATS are undeniable, a smaller aggression, better functional recovery by not sectioning muscles, producing minimal pain and having better cosmetic results. 5. In this study the complication rate was 13.8% without theatre mortality. 6. The global mortality, three cases (4.2%), is similar to that of conventional surgery and not chargeable to VATS, but to the patients' circumstances and type of operation. 7. VTE, as the first step in every operation for lung cancer, could reduce pure exploratory thoracotomy to 1.68%. The percentage of unresectable cases by VTE was 10.1%.
